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Eukaryotic cells attempt to maintain an optimal size,
resulting in size homeostasis. While cellular content
scales isometrically with cell size, allometric laws
indicate that metabolism per mass unit should
decline with increasing size. Here we use elutriation
and single-cell flow cytometry to analyze mitochon-
drial scaling with cell size. While mitochondrial con-
tent increases linearly, mitochondrial membrane po-
tential and oxidative phosphorylation are highest at
intermediate cell sizes. Thus, mitochondrial content
and functional scaling are uncoupled. The nonline-
arity of mitochondrial functionality is cell size, not
cell cycle, dependent, and it results in an optimal
cell size whereby cellular fitness and proliferative ca-
pacity are maximized. While optimal cell size is
controlled by growth factor signaling, its establish-
ment and maintenance requires mitochondrial dy-
namics, which can be controlled by the mevalonate
pathway. Thus, optimization of cellular fitness and
functionality through mitochondria can explain the
requirement for size control, as well as provide
means for its maintenance.
INTRODUCTION
For every cell type there is a typical cell size, possibly reflecting
the size for optimal cellular functions (Ginzberg et al., 2015).
Smaller size should be more efficient in nutrient uptake and
metabolism due to greater surface-to-volume ratio. However,
the very smallest cell size may not be ideal for cellular fitness
and functionality. What determines the optimal cell size is not
known. Cellular protein as well as organelle content typically
scales linearly with cell size (Reber and Goehring, 2015; Schmol-
ler and Skotheim, 2015), and it is commonly assumed that func-
tionality increases linearly with total protein and organelle con-
tent. For example, the well-established linear mitochondrial
content scaling (Kitami et al., 2012; Posakony et al., 1977; Rafel-
ski et al., 2012) is considered a metabolic adaptation to
increased cell size, as mitochondria are key organelles for
growth and proliferation. However, it is difficult to reconcile370 Developmental Cell 39, 370–382, November 7, 2016 ª 2016 The
This is an open access article under the CC BY license (http://creativehow linear size scaling of mitochondrial functionality, which re-
flects the metabolic activity of the cell, could help in establishing
an optimal cell size (Figure 1A). Instead, the presence of cell size-
dependent changes in functionality and/or feedback to meta-
bolic and growth processes have been considered critical for
cell size homeostasis (Ginzberg et al., 2015; Schmoller and Sko-
theim, 2015).
Allometry is the study of biological scaling relative to organ-
ismal size with a key interest in the relationship between organ-
ismal metabolic rate and body mass. Allometric scaling laws
were established through measurements of oxygen consump-
tion (reflecting mitochondrial activity) and body mass. These ex-
periments established that metabolic rate increases more slowly
than body size. Thus larger organisms have less active oxidative
metabolism per unit volume (Glazier, 2005; Kleiber, 1932). While
allometry has been extensively studied at the organismal level,
cellular allometry of metabolism and mitochondrial activity, i.e.,
how these functionalities scale with cell size, has not been care-
fully examined within the same cell population. Such analyses
could be important for understanding the regulation of cell
growth and cell size from evolutionary, biomedical, and biophys-
ical perspectives.
Previous studies have shown that cellular growth rates
are maximized in intermediate-sized phytoplankton species
(Maranon, 2015) and that growth rates decline in the largest
mammalian cells within a single population (Son et al., 2012;
Tzur et al., 2009). These results suggest that cell growth may
display nonlinear cellular allometry, whereby metabolic activity
is reduced at both ends of the cell size range (Figure S1A). This
is in stark contrast to the linear, isometric scaling of cellular pro-
tein and organelle content. Here we use both single-cell and
population-based analyses to study the cell size scaling of mito-
chondrial functionality in animal cells. We show that cells within a
single population exhibit an optimal cell size, wherebymitochon-
drial functionality and fitness are maximized.RESULTS
Mitochondrial Functionality Scales Nonlinearly with
Cell Size
We recently reported that the relative expression of many mito-
chondrial genes declines in cells larger than normal size in
cultured Drosophila cells and in mouse hepatocytes in vivo,
although the mitochondrial content per volume unit did notAuthors. Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
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Figure 1. Cell Size Scaling of Mitochondrial Membrane Potential and Respiration Are Nonlinear
(A) Cell size scaling of mitochondrial content is known to be linear, but how this translates to mitochondrial functionality is unknown.
(B) Flow cytometry data of Kc167 cells stained with ratiometric mitochondrial membrane potential (DJm) responsive JC-1 dye and plotted as a function of cell
size (forward scatter, FSC-A). Inset shows the correlation between total cellular protein (DDAO-SE) and mitochondrial content (JC-1 monomer).
(C) Computational cell size relation analysis for rDJm, the cell size normalized mitochondrial membrane potential. Untreated control cells as well as oligomycin-
and CCCP-treated cells were stained with JC-1 and measured with flow cytometry. The cells were computationally fractionated by size and median DJm was
calculated for each size fraction (bin). Gray plot shows the size distribution of the cell population. Individual data points display themedian rDJm for each cell size
with line depicting the local polynomial regression curve (typical rDJm trajectory with cell size). The percentages of cells smaller (‘‘reset phase’’) and larger
(‘‘allometric decline’’) in size than those with maximal rDJm are shown above the plot. n > 3.5 3 105 cells for each sample.
(D) Population-based analysis of mitochondrial content and rDJm with cell size. Kc167 cells were separated by centrifugal elutriation to size-based sub-
populations. Mitochondrial content andDJmweremeasured usingMitoTracker green and red, respectively, and normalized to cell size (FSC-A). Three replicates
for each subpopulation were measured and data were fitted using a trendline.
(E) Oxygen consumption parameters for elutriated subpopulations (lower panel) were measured using the Seahorse Extracellular Flux analyzer and normalized to
mean cell size of each subpopulation. Oxygen consumption data represent mean ± SD (n = 3–4).
See also Figures S1 and S2.change (Miettinen et al., 2014). Further analysis of proteome data
from a leukemia cell line separated by cell size (Ly et al., 2014)
showed that cell size scaling of proteins associated with different
organelles, including mitochondria, scales isometrically (Fig-
ure S1B). Asmitochondrial gene expression responds sensitively
to functional demands, these data lead us to hypothesize that
mitochondrial functional scaling could differ from the mitochon-
drial content scaling with cell size.
We wanted to analyze cell size scaling of mitochondrial func-
tionality in a steady state, unperturbed cell population, where
cell size differences reflect growth observed during the cell
cycle. To achieve this aim, we used flow cytometry-based
single-cell measurements together with JC-1 dye, which as
a ratiometric reporter provides cell size normalized (relative)
mitochondrial membrane potential (rDJm) measurements (see
Experimental Procedures). In a steady state DJm reflects the
balance between the rate of electron transport and the rate of
ATP utilization, thus providing a convenient measure for mito-
chondrial functionality. We also validated that the forward scat-ter (FSC-A) values provided by flow cytometry are accurate
measurements of cell size (Figures S1C and S1B). The flow cy-
tometry data consisting of cell size measurements (FSC-A) and
rDJm are computationally fractionated into size-based sub-
populations (bins) for which median rDJm is calculated and
used to fit a local polynomial regression curve (loess) that
visualizes the typical rDJm trajectory with cell size (Figure S2;
see also Experimental Procedures). In our approach, each cell
size bin corresponds to approximately 100 nm in cell diameter
based on calibration data. To overcome the high cell-to-cell
variability in DJm (Figures 1B and S2), we used 105–106 cells
for typical analysis.
Consistent with previous reports (Kitami et al., 2012; Posakony
et al., 1977; Rafelski et al., 2012), mitochondrial mass (as indi-
cated by the green JC-1 dye monomer fluorescence) increased
linearly with Drosophila Kc167 cell size (Pearson correlation R2 =
0.99; Figures 1B [inset], S2F). However, rDJmdisplayed a sharp
increase in the smallest cells followed by a slower decline toward
larger cells (Figure 1C). Similar cell size scaling of rDJm wasDevelopmental Cell 39, 370–382, November 7, 2016 371
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Figure 2. Cell Size Scaling of rDJm Is
Affected by Temperature and Cellular Meta-
bolism, but Not Cell Cycle
(A) Expected effect of temperature on cell size
scaling of rDJm. Metabolic theory predicts that
metabolic rate changes not only with size but also
with temperature (Gillooly et al., 2001), as indicated
by the equation. b is a general scaling constant, M
is mass, T is temperature, k is Boltzmann’s con-
stant, and E is the activation energy of metabolism.
Thus, increased temperature is expected to cause
a shallower decline in rDJm.
(B) Jurkat cells were incubated in complete me-
dium at different temperatures for 2 hr to adjust the
metabolic rate followed by JC-1 staining-based
analysis. Note that rDJm scaling does not change
further at the highest temperatures as cells
approach denaturating temperatures. n > 1 3 105
for each temperature point.
(C) Effect of mitochondrial nutrient source on cell
size scaling of rDJm. Glucose-grown cells utilize
both glycolysis and mitochondria for energy gen-
eration. Galactose-grown cells are reliant on mito-
chondrialmetabolism. Jurkat cellswere culturedon
glucose-containing medium or adapted to grow on
galactose followed by rDJm measurement. Dy
values show the magnitude of rDJm decline in the
linear range of the curve.
(D) DJm associates with cell size but not cell
cycle. Jurkat cells were stained with JC-1 and
NuclearRed ID DNA dye to visualize rDJm scaling
with cell size in each cell-cycle phase (top left) and
with DNA content (bottom right).
(E) Quantification of conditional information anal-
ysis of DJm association with cell size and cell
cycle showing the strength of DJm association
with cell size (S) and cell cycle (CC) from Jurkat
cells measured as shown in (D). Data shown
represent mean ± SD (n = 3) with >7.5 3 105 cells
per replicate.
See also Figure S3.observed in primary (e.g., human umbilical vein endothelial cells
[HUVECs]) and immortalized (e.g., Jurkat) cell types from various
species and also when using tetramethylrhodamine ethyl ester
(TMRE), another DJm-responsive dye (Figures S2L, and S1E).
The nonlinear scaling pattern of rDJm persisted when mito-
chondria were further polarized by blocking ATP synthase, and
was lost whenmitochondria were uncoupled (Figure 1C). Plasma
membrane potential did not display similar scaling with cell size
(Figure S1G).
We next examined the cell size scaling of mitochondrial
functions by first separating Kc167 cells into size-based sub-
populations using centrifugal elutriation. Mitochondrial mass,
as measured by MitoTracker green dye, remained constant in
different-sized cells after normalization to cell size. In contrast,
the DJm-dependent fluorescence of MitoTracker red dye
displayed a substantial decrease in both the smallest and
largest cells (Figure 1D). Consistent with the MitoTracker red
data, direct analysis of oxygen consumption indicated that
various parameters of mitochondrial respiration displayed a
nonlinear cell size scaling, whereby mitochondrial respiration
is highest in intermediate-sized cells (Figure 1E). These single-
cell and population-level data indicate that cell size scaling of372 Developmental Cell 39, 370–382, November 7, 2016mitochondrial content and functionality are distinct from each
other, as mitochondrial functionality is maximized in intermedi-
ate-sized cells.
Scaling of Mitochondrial Membrane Potential Is Cell
Size, Not Cell Cycle, Dependent
We reasoned that if the rDJm scaling is indeed cell size depen-
dent and related to the allometric decline in metabolic rate, we
should also observe temperature dependency as predicted by
the Arrhenius equation (Gillooly et al., 2001) (Figure 2A). We
measured the cell size scaling of rDJm at temperatures ranging
from 33C to 41C in Jurkat cells and observed a stronger
decline in rDJm scaling with lower temperatures, a result
consistent with the theory (Figure 2B). In addition, Drosophila
cells, which are cultured at 23.5C, display a stronger decline
in rDJm toward larger cells than Jurkat cells, which are cultured
at 37C (compare Figures 1C and 2B).
We next examined the nutrient dependency of rDJm scaling.
We cultured Jurkat cells in galactose-containing medium to in-
crease their dependency on mitochondrial activity. In compari-
son with Jurkat cells grown in glucose-containing medium,
galactose-grown cells displayed higher rDJm in smaller cells
and a slightly stronger decline in rDJm in larger cells (Figure 2C).
These data suggests that the observed mitochondrial functional
scaling is due to the mitochondria in smallest and largest cells
being less active than their mid-sized counterparts, although
mitochondria in all sizes of cells remain functional (see also Fig-
ure 1C). Thus, the rDJm decrease in larger cells could be ex-
plained by reduced metabolic activity caused by the increase
in cell size, possibly through changes in surface-to-volume ratio.
The low rDJm in the very smallest cells may be a ‘‘newborn
effect,’’ whereby the small daughter cells are yet to reset their
inherited low metabolic activity after mitosis.
As cells grow larger within the cell cycle, we next examined
whether the DJm changes are size specific or whether they
could be better explained by the cell cycle. Analysis of human
Jurkat cells and HUVECs stained for rDJm and DNA content
indicated that rDJm declines also with the cell cycle, as ex-
pected. However, analysis of rDJm as a function of cell size
separately in G1, S, and G2/M phases of the cell cycle revealed
that rDJm scaling with cell size behaves similarly regardless of
the cell-cycle phase (Figures 2D, S3B, and S3E). Comparison
of the size-dependent change in rDJm within a single cell-cycle
phase with the cell-cycle-dependent change in cells of the same
size indicated that the rDJm change is 5–10 times greater with
cell size than between the cell-cycle phases in Jurkat cells and
HUVECs (Figures S3D and S3F). We also used Shannon’s infor-
mation theory (conditional mutual information) (Shannon, 1948)
to quantify the association of DJm with cell size = S, when cell
cycle is fixed, i.e., I(DJm, SjCC) and with cell cycle = CC,
when cell size is fixed, i.e., I(DJm, CCjS). rDJm displayed
40 times stronger association with cell size than the cell cycle
in Jurkat cells (p = 0.001, t test) (Figure 2E). In conclusion,
rDJm is dependent on cell size, not the cell cycle, as could
be predicted from allometric laws (Glazier, 2005; Kleiber, 1932;
Kozlowski et al., 2003).
Cell Size Scaling of Mitochondrial Functions Sets the
Optimal Cell Size
Wenext askedwhat are the consequences resulting from the un-
coupling of mitochondrial content and function. Apoptosis and
heterogeneity are determinants of mitochondrial and cellular
fitness.We therefore examinedwhethermetabolic heterogeneity
(measured as coefficient of variability of DJm) is minimized at
any particular cell size and whether this is related to cellular
fitness. Minimum rDJm variability was found to be associated
with the median cell size in the Kc167 population using both
JC-1 and TMRE dyes (Figures 3A and S1E). Similarly, there
was a strong correlation between minimum variability and me-
dian cell size across primary and immortalized cell types from
multiple organisms (Figure 3B). Measurement of apoptosis using
phosphatidylserine exposure indicated that the number of dying
cells increases especially in the smallest but also in the largest
Kc167 cells (Figure 3C). These cells were early apoptotic cells,
as our experiments exclude the cell population with compro-
mised plasma membrane integrity (see Experimental Pro-
cedures). Furthermore, the cell size dependency pattern of
apoptosis strongly correlated with the DJm variability (R2 =
0.94, Figure 3C inset), supporting the concept that a low DJm
variability is beneficial for cellular fitness. These data, together
with the cell size scaling of oxygen consumption, suggest thatmitochondrial functions and fitness are optimized in intermedi-
ate-sized cells within a single population.
Cellular fitness is commonly evaluated by measuring cell pro-
liferation, which for cells in nutrient-rich culture conditions can
also be considered as a measure of the growth rate (production
of cellular biomass). We separated Kc167 cells, HUVECs, and
Jurkat cells into subpopulations with different cell sizes and
thereafter allowed them to proliferate in complete culture
medium. As with mitochondrial respiration (see Figure 1E), the
average-sized cell populations appeared optimal, resulting in
the highest number of cells (Figure 3D). Similar results were ob-
tained when cells of different sizes were not physically separated
but proliferation was analyzed using fluorescent dye dilution
upon cell division (Miettinen and Bjorklund, 2015) (Figures
S4A–S4C). To analyze the role of mitochondria more directly,
we sorted Jurkat cells first by size using elutriation and then by
rDJm using fluorescence-activated cell sorting, to obtain popu-
lations with low, medium, and high rDJm (Figure 3E). Within
the same-sized cells, medium and high rDJm cells were more
proliferative than low rDJm cells, indicating that mitochondrial
activity promotes cellular fitness (Figure 3E). To further test the
connection between rDJm and cellular fitness and growth
rate, we measured Jurkat cell DJm and protein synthesis
rates with MitoTracker red and O-propargyl-puromycin (OPP),
respectively. The rDJm explained up to 75% of the variability
in protein synthesis rates (Figure 3F, R2 = 0.74), suggesting
that mitochondrial activity is a key factor behind variability in
cellular growth rate. Altogether, these experiments indicate
that intermediate-sized cells within a population have the best
cellular fitness, which is supported by optimal mitochondrial
activity and minimal mitochondrial variability.
Cells Aim to Maintain Their Optimal Cell Size
We next analyzed whether cells separated by size return to their
original size distribution, as this would be indicative of an
optimal cell size (Figure 4A). Jurkat cells were elutriated into
six fractions, and the mean sizes and size distributions of these
subpopulations were measured at 0 hr and 100 hr. After 100 hr
in culture, the median cell sizes of the subpopulations were
indistinguishable from the median size of the original population
(Figure 4B). As the resumption of normal cell size took a signif-
icant amount of time, the data suggest that potential cell size
checkpoint(s) is/are not able to immediately reset cell size
back to the optimal size. The narrower size distributions ob-
tained by elutriation also broadened to resemble the original
size distribution (Figure 4C). This widening of the size distribu-
tion also took place in the intermediate-sized subpopulation.
While this might suggest that some cells are moving away
from the optimal cell size, this widening of the size distribution
mostly reflects the re-establishment of the normal cell-cycle dis-
tribution. This is because the selection of intermediate-sized
cells by elutriation results in a cell population that is not only
average in cell size but also highly enriched in cells in the middle
of the cell cycle. Altogether, these data suggest that cells aim
to maintain an optimal cell size at the population level. How-
ever, cells also maintain a size variation around the optimal
cell size, as it is necessary to allow progression through the
cell cycle. Similar results were observed in Kc167 cells (Figures
S4D and S4E).Developmental Cell 39, 370–382, November 7, 2016 373
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Figure 3. Cell Size Scaling of Mitochondrial Functions Establishes the Optimal Cell Size with Maximal Cellular Fitness
(A) Minimum of DJm variability associates with median cell size. Same data as in Figure 1B were analyzed for cell-to-cell variability in DJm. CV, coefficient of
variability.
(B) Correlation between cell size with minimum DJm variability and median cell size in cells of human (green), rat (orange), chicken (pink), and Drosophila (blue).
(C) Levels of apoptotic cells as a function of cell size as analyzed by an annexin-based biosensor (pSIVA) and normalized for cell size using cellular protein content
using amino-reactive DDAO-SE dye (Miettinen and Bjorklund, 2015). Inset: Pearson correlation of apoptosis withDJmvariability in each size of cell. n > 2.53 105
cells.
(D) Cell size scaling of overall cellular fitness, as measured by proliferative capacity. Kc167 cells, HUVECs, and Jurkat cells were separated to size-based
subpopulations and equal numbers of cells were cultured for 72 hr (Kc167 and HUVECs) or 100 hr (Jurkat) before the final cell numbers were counted. Top right
displays statistical analysis (ANOVA with Tukey’s post hoc test) of Kc167 data (n = 12).
(E) Effect of rDJmon cell proliferation. Jurkat cells were first separated by size and then by flow sorting to populations with different rDJm.Cells were cultured for
100 hr (n = 6) and analyzed as in (D).
(F) Correlation between DJm (MitoTracker red) and protein synthesis rate (OPP incorporation) in individual Jurkat cells (n = 3.1 3 104 cells). Both fluorescence
signals were normalized to cell size (FSC-A).
See also Figure S4.Insulin Signaling Controls the Optimal Cell Size, but Not
the Allometry, in Mitochondrial Functionality
Growth factor signaling is a key determinant in controlling
average cell size at the population level in multicellular
organisms, the insulin/mTOR (mammalian target of rapamycin)
pathway being particularly important for cell size (Lloyd, 2013).374 Developmental Cell 39, 370–382, November 7, 2016To analyze how insulin signaling contributes to the optimal cell
size andmitochondrial functional scaling, we treated Kc167 cells
with insulin and rapamycin. While rapamycin decreased and in-
sulin increased the cell size, scaling of mitochondrial function-
ality followed the new cell size distribution. The scaling remained
nearly identical, as quantified by analyzing the correlations
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Figure 4. Cells Aim to Maintain Optimal Cell
Size
(A) Schematic of the experimental setup. Cells
are separated into size-based subpopulations
by elutriation and returned to culture. After
100 hr, mean cell size and size distribution are
measured using flow cytometry to see whether
the cell populations maintain their original
median size and discover the resulting cell size
distribution.
(B) Mean cell size in each Jurkat cell subpopulation
immediately after elutriation (0 hr, blue) and after
100 hr in culture (red). The data shown represent
percent change versus unsorted original popula-
tion. The size changes after 100 hr are statistically
nonsignificant (two-tailed t test) (n = 3 in each
subpopulation).
(C) Size distributions of the original Jurkat cell
population as well as smallest, average-sized,
and largest subpopulations after 0 hr (blue)
and 100 hr (red). The cell size distributions
are illustrated with violin plots, and the inset
above displays a comparison between a typical
density plot and a violin plot representation
of the data. White oval represents the median
size and the thicker black line shows the first
and third quartile (Q1 and Q3, where 25%
and 75% of the data are below these points, respectively). CV is shown below the size distribution plots. Data shown represent mean ± SD (n = 3) from
1–5 3 104 cells per sample. The gray dotted line indicates the median cell size in the original population.
See also Figure S4.between cell size normalized rDJm medians and variabilities
(R2 = 0.94 and 0.96, respectively, Figure 5A). Similar results
were seen in Jurkat cells (Figure S5). Thus, insulin/mTOR
signaling controls the average cell size but does not affect the
scaling of mitochondrial functionality or the association of mini-
mum rDJm variability with median cell size. Insulin signaling,
and possibly growth factors in general, therefore controls the
optimal cell size, but not necessarily its establishment and main-
tenance through mitochondria. It is possible that, as mTOR pro-
motes mitochondrial biogenesis, mTOR activity has a much
larger impact on the mitochondrial content than function.
Mitochondrial Fusion and Fission Control the Cell Size
Scaling of Mitochondrial Functions
We next wanted to identify which intrinsic processes are
required for the observed allometric scaling of mitochondrial
functionality. Changes in mitochondrial fusion and fission are
tightly linked to DJm (Chen et al., 2005; Legros et al., 2002) as
well as mitochondrial homogeneity (Chan and Marshall, 2012).
Furthermore, mitochondrial dynamics are predicted to affect
cellular functions in a nonlinear manner (Hoitzing et al., 2015).
We therefore asked whether mitochondrial fusion and fission
affect the cell size scaling of mitochondrial functionality. Genetic
inhibition of the mitochondrial dynamics by RNAi of the fission-
regulating guanosine triphosphatase Drp1 and the fusion-regu-
lating mitofusins perturbed the cell size scaling of rDJm in
Kc167 and Jurkat cells. Drp1 knockdown increased rDJm in
larger cells, whereas mitofusin knockdown caused opposite ef-
fects (Figures 5B and 5C). As expected, a small-molecule inhib-
itor of mitochondrial division, Mdivi-1, induced effects similar to
those of Drp1 RNAi (Figure 5D). Inhibition of mitochondrial divi-sion also increased cell size. Furthermore, inhibition of mito-
chondrial fusion and fission also shifted the cell size with minimal
DJm variability (Figure 5B, right). These data suggest that mito-
chondrial dynamics or normal mitochondrial morphology is
required for the typical cell size scaling of mitochondrial func-
tions and themaintenance of optimal cell size. To further validate
this, we analyzed Kc167 cell size scaling of mitochondrial respi-
ration in the presence of Mdivi-1. In contrast to the untreated
control cells (Figure 1E), Mdivi-1 treatment resulted in increased
respiration in the largest cells (Figures 5E and S5F), as suggested
by the changes in rDJm.
The Mevalonate Pathway Is Required for Cell Size
Scaling of Mitochondrial Functions
The mevalonate pathway is important for cellular and organelle
homeostasis by providing plasma membrane (cholesterol) and
electron transport chain components (ubiquinones/coenzyme
Q) as well as isoprenyls, which are required for post-translational
modifications of proteins (Figure 6A).We previously identified the
mevalonate pathway as a cell size regulator (Miettinen and Bjor-
klund, 2015; Miettinen et al., 2014), and this pathway has been
shown to affect mitochondria (Andreux et al., 2014; Liu et al.,
2014). We therefore examined how the mevalonate pathway af-
fects the cell size scaling of mitochondrial functionality. In
Kc167 cells inhibition of the mevalonate pathway by pitavastatin
resulted in increased rDJm in larger cells (Figure 6B), consistent
with the statin-induced DJm increase in other cell types (An-
dreux et al., 2014). These effects were rescued by mevalonate,
the metabolite immediately downstream of the statin target
HMG-CoA reductase (Figure 6B). Further downstream of the
mevalonate pathway the statin-induced scaling effects wereDevelopmental Cell 39, 370–382, November 7, 2016 375
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Figure 5. Mitochondrial Dynamics Regulate Cell Size Scaling of Mitochondrial Functions
(A) Insulin signaling controls optimal cell size without changing the scaling of rDJm. Kc167 cells were treated with insulin and rapamycin for 14 hr and rDJmwas
analyzed with JC-1 staining. The 3D plots display median (left) and variability (right) of rDJm for each cell size bin after normalizing for the overall cell size change.
Insets display size distribution and scaling of rDJm and its variability. n > 2 3 105 cells.
(B) Cell size scaling of rDJm (left) and its cell-to-cell variability (right) in Kc167 cells after 5 days of double-stranded RNA-mediated knockdown of Drp1 and Marf
(mitofusin). Arrows indicate the cell size with the minimum variability. n > 1.7 3 105 cells.
(C) Cell size scaling of rDJm in Jurkat cells after 65 hr of small interfering RNA-mediated knockdown of DRP1 andMNF2 (mitofusin 2). Inset displays western blot
of the knockdown efficiency. n > 1.2 3 105 cells.
(D) Kc167 cell rDJm (left) and variability (right) changes after 6 and 24 hr of treatment with the Drp1 inhibitor Mdivi-1. Arrows indicate the cell size with the
minimum variability. n > 2.5 3 105 cells.
(E) The changes in the rDJmcaused byMdivi-1 translate into increased oxygen consumption in the largest cells. Kc167 cells treatedwithMdivi-1 were separated
by centrifugal elutriation to size-based subpopulations (bottom panel) from which oxygen consumption parameters were analyzed. Oxygen consumption data
represent mean ± SD (n = 3–4).
See also Figure S5.rescued by farnesyl pyrophosphate and geranylgeranyl pyro-
phosphate (GGPP), isoprenyls required for protein prenylation
(Figure 6B). Although ubiquinones are critical for mitochondrial
electron transport chain function, the cell-permeable ubiquinone
analog decylubiquinone did not rescue the statin phenotype (Fig-
ure 6B). Also, the statin-induced changes in rDJmcannot be due
to cholesterol, as the Kc167 cells are incapable of de novo
cholesterol synthesis. Consistently, inhibition of cholesterol syn-
thesis downstreamof farnesyl pyrophosphate did not change the376 Developmental Cell 39, 370–382, November 7, 2016cell size scaling of mitochondrial functionality (Figure S6A).
Together, these results indicate that the mevalonate pathway
and, more specifically, protein prenylation is required for the
typical cell size scaling of rDJm observed in untreated cells.
We next investigated whether the mevalonate pathway could
also affect the optimal cell size. Statin treatment dissociated
the rDJm variability from the Kc167 median population cell
size and this effect was rescued by GGPP supplementation (Fig-
ure 6C), suggesting that the mevalonate pathway is required for
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Figure 6. The Mevalonate Pathway-Mediated Protein Prenylation Is Required for Normal Cell Size Scaling of Mitochondrial Functions
(A) Schematic of the mevalonate pathway. Chemical inhibitors used are shown in red. *Note that Drosophila cells are incapable of de novo cholesterol synthesis.
(B) Mevalonate pathway regulates cell size scaling of rDJm through protein prenylation. Cell size scaling of rDJm in Kc167 cells treated with pitavastatin and
indicated metabolites for 72 hr. n > 2 3 105 cells.
(C) Cell size scaling of rDJm variability after 72 hr of treatment with statin. The statin effects were fully rescued by GGPP. Arrows indicate the cell size with the
minimum variability. n > 2 3 105 cells.
(D) Cell size scaling of respiration in control Kc167 cells. The experiment carried out as in Figure 1E. Data represent mean ± SD (n = 4).
(E) Same as (D), but cells were treated with statin for 72 hr before the oxygen consumption assay. Data represent mean ± SD (n = 2–4).
See also Figure S6.maintaining the optimal cell size. We validated this by measuring
the cell size-dependent oxygen consumption for statin-treated
Kc167 cells. In contrast to the control cells (Figure 6D), where
the relative oxygen consumption was reduced in larger cells
(as also seen in Figure 1E), statin treatment caused oxygen con-
sumption to increase even in the very largest cells (Figure 6E).
We also examined if the altered cell size scaling of rDJmcould
be due to inhibition of late autophagy and consequential mito-
chondrial accumulation (Miettinen and Bjorklund, 2015). Inhibi-
tors of autophagy did not change the cell size scaling of rDJm(Figure S6B), and pitavastatin and Mdivi-1 treatments increased
mitochondrial content proportionally to cell size (Figure S6C).
Thus, altered autophagy and mitophagy cannot explain the
statin-induced phenotype.
Wenext performed time-course analysesofMdivi-1 andstatin-
induced changes in DJm variability and population cell size to
examine the relationship between these aspects in more detail.
Mdivi-1 linearly increased cell size and changes in rDJm (Fig-
ure S6D). In contrast, rDJm, its variability, and cell size re-
sponded to pitavastatin after a 24-hr delay, further suggestingDevelopmental Cell 39, 370–382, November 7, 2016 377
that depletion of one ormore prenylated proteins is necessary for
these effects (Figure S6E). After this initial lag phase, both the cell
size with minimum rDJm variability and the median population
cell size slightly decreased, followed by a final increase. Overall,
the median population cell size and rDJm changed with very
similar time delays, indicating tight coupling of these processes.
Finally, the statin-induced mitochondrial effects were not cell
type or statin specific as they were also observed with another
statin and in both Kc167 and Jurkat cells (Figure S6F). In conclu-
sion, the mevalonate pathway is required for the cell size scaling
of and the optimal cell size for mitochondrial functionality.
The Mevalonate Pathway Regulates Mitochondrial Size
and Morphology
As the statin-induced mitochondrial functional scaling effects
resembled those caused by Drp1 inhibition, we studied how
the mevalonate pathway affects mitochondrial dynamics. We
first isolated mitochondria from cells treated with statins and
analyzed mitochondrial sizes using flow cytometry (Dabkowski
et al., 2009; Song et al., 2015). Statin treatment of Jurkat and
Kc167 cells increased the proportion of larger mitochondria,
and this was prevented by addition of mevalonate or GGPP (Fig-
ures 7A and S7A). Microscopic observations validated that this
analysis of isolated mitochondria could identify different-sized
mitochondria, although the majority of them were round (Fig-
ure 7B). Thus, mitochondrial isolation allows size measurements
but does not preserve mitochondrial morphology. We then
examined the effects of mevalonate pathway inhibition on mito-
chondrial morphology using MitoTracker-red-stained and para-
formaldehyde-fixed Jurkat and Kc167 cells. We found that the
mevalonate pathway inhibition increases the number of enlarged
tubular mitochondria (Figures 7C and S7B), consistent with
observations in Caenorhabditis elegans (Liu et al., 2014). The
morphology of statin-treated mitochondria was distinct from
Mdivi-1-induced effects, and the statin effects were rescued
by the addition of GGPP.
Mitochondrial morphology may be affected by fixation as well
as mitochondrial dyes. To avoid such biases in our analysis, we
further performed live cell experiments with Jurkat cells stained
with MitoTracker green, which is structurally unrelated to Mito-
Tracker red. MitoTracker-green-stained cells also displayed a
more extensive tubular mitochondrial network in statin-treated
cells than in control cells (Figures 7D and S7C). Quantitative
analysis of mitochondrial volumes confirmed that statin-treated
cells have significantly larger average mitochondrial size
compared with controls (p = 3.5 3 106, two-tailed t test) (Fig-
ures 7E and S7D). This increase in mitochondrial size could, in
theory, be due to inhibition of mitochondrial fragmentation. We
therefore analyzed U2OS cells expressing mitochondria-tar-
geted mCherry-GFP fusion protein (Allen et al., 2013) before
and after disruption of the mitochondrial network by the mito-
chondrial uncoupler carbonyl cyanide 4-(trifluoromethoxy)phe-
nylhydrazone (FCCP). U2OS cells display a well-connected
mitochondrial network, which was efficiently fragmented by
FCCP. This fragmentation could not be prevented, although it
was potentially reduced in pitavastatin and Mdivi-1 treated cells
(Figures 7F and 7G). Altogether, these analyses indicate that
mitochondrial size and morphology is affected by the mevalo-
nate pathway.378 Developmental Cell 39, 370–382, November 7, 2016DISCUSSION
In contrast to the isometric cell size scaling of mitochondrial con-
tent, we report a nonproportional scaling of mitochondrial func-
tions with cell size. Our results suggest that the physiological
consequence of this nonlinear mitochondrial functional scaling
is the establishment of an optimal cell size, as also supported
by the known decline of growth rate in the largest cells (Maranon,
2015; Son et al., 2012; Tzur et al., 2009). These findings extend
the allometric scaling laws on metabolism to the cellular level,
as previously predicted (Kozlowski et al., 2003), and suggest
that the allometric laws apply to the normal growth regime within
a cell cycle. Nearly 20 years ago West, Brown, and Enquist pro-
vided a general model to explain allometric laws through trans-
port of materials and energy through space-filling fractal net-
works of branching tubes (West et al., 1997). Only recently, it
was shown thatmitochondriamay promote intracellular resource
distribution by providing a conductive pathway for energy supply
(Glancy et al., 2015).Wenowobserve that the cellular allometry of
mitochondrial metabolism is controlled by mitochondrial fusion
and fission. It is thus possible that mitochondrial dynamics could
influence cellular resource distribution by controlling the forma-
tion of a highly connected fractal-like mitochondrial network.
This implies that a highly connectedmitochondrial network could
promote growth, improve fitness, and enable larger cell size by
counteracting the biophysical limitations in resource distribution.
We also find that the mevalonate pathway affects mitochon-
drial dynamics and scaling of mitochondrial functionality. The
mevalonate pathway, which produces various plasma mem-
brane components, including cholesterol, could potentially act
as a reporter for cell surface-to-volume ratio and relay this infor-
mation to mitochondria via protein prenylation to maintain
optimal cell size. It was recently shown that the levels of many
proteins and metabolites in the mevalonate pathway are
reduced in mitofusin knockout cells (Mourier et al., 2015), sug-
gesting that mitochondrial dynamics can influence mevalonate
pathway activity. This, together with our findings that the meval-
onate pathway regulates cell size (Miettinen andBjorklund, 2015)
and mitochondrial dynamics, suggests that the mevalonate
pathway and mitochondrial dynamics may constitute a growth
and cell size regulatory network.
Finally, conditions such as cardiac hypertrophy and cellular
aging are characterized by abnormal increases in cell size and
reduced mitochondrial functionality. The potential implication
of our current and previous (Miettinen and Bjorklund, 2015; Miet-
tinen et al., 2014) observations is that changes in cell size
may affect mitochondrial functionality. Thus, cell size may affect
mitochondrial functions in various physiological and pathological
settings (Lloyd, 2013; Nunnari and Suomalainen, 2012), making
cell size-induced metabolic changes directly relevant for devel-
opment and disease.
EXPERIMENTAL PROCEDURES
Full details are provided in Supplemental Experimental Procedures.
Cell Culture and Chemical Treatments
Kc167 cells were cultured in Schneider’s Drosophila medium supplemented
with 10% fetal bovine serum (FBS), penicillin, and streptomycin. Jurkat cells
were cultured in high-glucose RPMI supplemented with 10% FBS, penicillin,
Figure 7. The Mevalonate Pathway Regulates Mitochondrial Volume and Morphology
(A) Statins increase the size of isolated mitochondria. Flow cytometry-based size analysis of isolated mitochondria from Jurkat cells. Cells were treated with
indicated chemicals for 72 hr. Data represent mean ± SD (n = 3).
(B) Representative maximum-intensity projections of MitoTracker-green-stained, isolated mitochondria from Jurkat cells. Scale bars, 2.5 mm.
(C) Representative binary images of Jurkat cell mitochondria. Insets show maximum-intensity projections of fixed Jurkat cells stained with DAPI (nucleus, blue)
and MitoTracker red (mitochondria, red) after treatment with indicated chemicals. Statin treatment was for 72 hr and Mdivi-1 treatment for 12 hr. Scale bars,
10 mm.
(D) Representative 3D projections of live Jurkat cell mitochondria after 72 hr of treatment with statin. Cells were stained with MitoTracker green and CellMask
Deep Red plasma membrane stain.
(E) Statins increase mitochondrial volume in live cells. Quantification of average mitochondrial volume within each Jurkat cell from samples shown in (D) (n = 48
[control] and 51 [pitavastatin], p value is from a t test).
(F) Representative maximum-intensity projections, and their zoom-ins, of U2OS cells expressing mitochondria-targeted mCherry-GFP fusion after 72 hr of statin
treatment or 24 hr of Mdivi-1 treatment. Scale bars, 10 mm.
(G) Same as (F), except that cells were treated with 2 mM FCCP for 1 hr to induce mitochondrial fragmentation. Scale bars, 10 mm.
See also Figure S7.
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streptomycin, and L-glutamine. In addition, the following cell lines were used in
some experiments: yeast BY4741 cells, Drosophila cells, Clone 8 and S2R+
cells, chicken DT40 cells, and human NB4 and U2OS stably expressing
mCherry-GFP-FIS1 (amino acids 101–152) cells. Primary HUVECs and rat he-
patocytes were from Life Technologies. All cell lines have been tested negative
for mycoplasma. All chemicals were obtained from Sigma-Aldrich, unless
otherwise stated. Concentrations used were 1 mM CCCP, 10 mM oligomycin,
50 mM Mdivi-1, 5 mM pitavastatin, 5 mM atorvastatin, 40 mM rosuvastatin,
20 mM decylubiquinone, 20 mM farnesyl pyrophosphate, 20 mM GGPP, and
0.2 mM mevalolactone. Note that the used statin concentrations exhibit only
a modest toxicity in the cell lines used (Miettinen and Bjorklund, 2015), that
cell toxicity does not explain the altered cell size scaling of rDJm (data not
shown), and that the statin-induced rDJm effects were seen in Drosophila
cells, which are incapable of de novo cholesterol synthesis.
Fluorescence Probes
A common oversight in cell biology is that fluorescent markers are not normal-
ized to cell size. We used JC-1 dye (Smiley et al., 1991) to measure DJm
(unless otherwise indicated), as the ratiometric nature of this probe inherently
normalizes the data with mitochondrial content, but also to cell size due to iso-
metric scaling of mitochondrial content (see Figures 1B and S2G). Thus JC-1
dye reports the relative (cell size normalized) DJm (rDJm). In a typical exper-
iment, JC-1 staining time was 45 min with 2 mM dye concentration. Stainings
were performed at the normal cell-culture temperature for each cell line
(23.5C forDrosophila cells, 37C for mammalian cells). All fluorescence inten-
sities, cell counts, and sizes weremeasured using an Accuri C6 flow cytometer
(Becton Dickinson).
Computational Cell Size Relation Analysis of DJm
To analyze the fluorescence signals, and thus cell behavior, as a function of cell
size, we devised a new flow cytometer-based single-cell approach dubbed
computational size relation analysis (CoSRA). Single-cell data falling into a
viable cell gate, as estimated using plasma membrane integrity based on
propidium iodide exclusion was used to define the viable cell population (Fig-
ure S2B). Data were exported from the flow cytometer and analyzed in R envi-
ronment (R version 3.1.0). FL2-A/FL1-A ratio representing the JC-1 aggregate/
monomer ratio was calculated for each cell and the cells were then computa-
tionally fractionated into size-based subpopulations (these bins are typically
53 104 FSC-A units, which corresponds to approximately 100 nm in diameter
based on calibration data presented in Figures S1C and S1D). Median fluores-
cence intensities were calculated for each bin. When comparing the cell size
scaling of rDJmafter different cellular perturbations, the median rDJmvalues
were normalized to the bin with the highest median rDJm. Oligomycin, CCCP,
and valinomycin treatments were normalized to the maximum of the control
sample. A local polynomial regression (loess) curve was fitted to the median
values using the built-in R function loess. The 95% confidence intervals for
the loess curve were estimated using the predict function. Finally, medians
(dots), loess regression line (solid curve), and confidence intervals for the
regression line (shaded area) were plotted as a function of cell size (FSC-A)
in the same plot with a cell size distribution histogram. The global minima of
the variability were identified from the loess regression fit and indicated with
vertical arrows. To increase figure clarity, we have removed individual data
points (median or coefficient of variability [CV] of rDJm in each bin) from
most figures. The resulting regression curve displays the typical trajectory of
the measured parameter as a function of cell size. Note that the CoSRA
approach is not limited to analyzing the cell size scaling of rDJm, as any
cellular parameter for which a suitable fluorescence-based reporter is avail-
able can be used (see Figure S1 for examples).
Analyzing the Contribution of Cell Size and Cell Cycle to the rDJm
To analyze the cell size dependency of DJm, we applied mutual information
analysis from Shannon’s information theory. Shannon’s information theory
provides a general model by which to measure dependencies between vari-
ables, even if there is no linear dependence between these variables (Steuer
et al., 2002). In information theory, mutual information is the average amount
of information about U from observing the value of V. In particular, conditional
mutual information expressed as I(U; VjW) provides an estimate of the quantity
of information shared between U and V when W is known (fixed). We can thus380 Developmental Cell 39, 370–382, November 7, 2016estimate the association between rDJm and cell size (S), when the cell-cycle
(CC) status of the cells is known, i.e., I(rDJm; SjCC). If cell size S carries infor-
mation regarding rDJm, which is not already contained in CC information, the
conditional mutual information yields a value >0. Zero value means lack of
additional information between the variables rDJm and S, given that CC is
known. Mutual information can thus have values of zero to infinity (0 . N);
however, this value directly has no obvious interpretation, but by comparing
I(rDJm; SjCC) and I(rDJm; CCjS), the relative information content carried
by size and cell cycle can be analyzed.
Size Separation by Centrifugal Elutriation
To examine size-dependent changes using population-based assays, we
separated cells into size-based subpopulations using centrifugal elutriation.
Approximately 3 3 108 cells were resuspended in 3 mL of PBS with 1%
FBS. Cells were loaded into a counterflow centrifugal elutriator (Beckman
JE-5.0/JE), equipped with a standard elutriation chamber and a peristaltic
pump (see Supplemental Experimental Procedures for details). Collected cells
were resuspended in culture medium, and cell size and counts were analyzed
using flow cytometry. Mitochondrial mass andmembrane potential from elutri-
ated fractions were measured using MitoTracker green FM and MitoTracker
red CMXRos, respectively. Flow cytometry-measured MitoTracker intensities
were normalized to mean FSC-A values.
Oxygen Consumption Measurements
Oxygen consumption wasmeasured using an XF24 Extracellular Flux Analyzer
(Seahorse Bioscience). The assay plates were coated with poly-L-lysine, and
80,000 Kc167 cells were plated on each well 2 hr before the analysis. The
analysis was carried out in Schneider’s cell-culture medium with 10% FBS
at room temperature. Oxygen consumption was measured every 6 min and
the following injections were performed after every four measurements: (1)
1 mM oligomycin, (2) 1 mM FCCP, and (3) 2 mM rotenone and 2 mM antimycin
A (see Supplemental Experimental Procedures for details). For each replicate
the four oxygen consumption measurements between each injection were
averaged, after which the respiratory parameters were calculated. All the re-
sults were normalized to the subpopulation cell size (FSC-A). The analysis
was also carried out after treating cells with the mitochondrial division inhibitor
Mdivi-1 (50 mM) for 24 hr or pitavastatin (5 mM) for 72 hr. Mdivi-1 and pitavas-
tatin were present for the whole duration of the oxygen consumption assay.
Proliferation Measurements
For proliferation-based fitness measurements, Kc167 cells, Jurkat cells, and
HUVECswere first separated into size-based subpopulations using centrifugal
elutriation. The average cell size in each subpopulation was measured using
flow cytometry, and an equal cell count of each subpopulation was taken for
further culture in normal conditions. The final data are presented as relative
cell counts after indicated culture time (y axis) as a function of the initial sub-
population cell size (x axis). The total cell population histogram is also shown
for reference. For Kc167 cells the differences in proliferative capacity of
different-sized cells were highlighted by presenting the data as a box plot.
The effect of mitochondrial membrane potential on cell proliferation was
analyzed in Jurkat cells by first using centrifugal elutriation to separate two
different-sized subpopulations. These cells were then stained with TMRE
and cells with high, medium, and low rDJm (thus taking cell size into account
in assessing the DJm, see schematic in Figure 2E) were separated using flow
sorting (Influx Cell Sorter, Becton Dickinson), and cell sizes were reanalyzed in
the separated populations to validate that rDJm-based separation did not
change the average cell size. Equal cell counts of these rDJm-separated cells
were then cultured for 100 hr in normal growth conditions, after which cells
were recounted.
When analyzing cell proliferation using the CoSRA method (see above),
cells were first stained using DDAO-SE dye and the baseline staining levels
were measured using flow cytometry. The cells were then cultured normally
for 48 hr after which cells were reanalyzed for DDAO-SE stain dilution (see
Figure S5A).
Protein Synthesis Measurements
Jurkat cells were stained with Click-iT Plus OPP Alexa Fluor 488 Protein Syn-
thesis Assay Kit (LifeTechnologies) and MitoTracker red CMXRos. OPP and
MitoTracker red were added to 20 mMand 200 nM final concentration, respec-
tively, and incubated for 30 min. Cells were fixed with 3.7% formaldehyde and
processed as instructed in the OPP assay kit. Cells were analyzed using flow
cytometry.
Microscopy
For examination of mitochondrial morphology, Kc167 and Jurkat cells
were treated with indicated chemicals and moved to coverslips coated with
0.1% poly-L-lysine. The cells were stained with MitoTracker red CMXRos
or MitoTracker green with CellMask Deep Red. U2OS cells expressing
mCherry-GFP were imaged in the absence of any stains. For live cell imaging,
cells were incubated at 37C and 5% CO2 in complete culture medium during
the experiment. Cells were imaged with a DeltaVision wide-field deconvolution
microscope using standard filters (DAPI, fluorescein isothiocyanate, tetrame-
thylrhodamine isothiocyanate, Cy5) and 1003 objective. For details of image
processing, see Supplemental Information.
Statistical Analyses
Pearson correlations (R2) were calculated using the square of the cor function
in R. When comparing the cell size scaling of rDJm after modulations to the
insulin signaling pathway, the correlations between the median rDJm values
in each cell size bin were calculated after normalizing for the cell size change
caused by insulin or rapamycin. Statistical significances were calculated using
one-way ANOVA and Tukey’s post hoc test or t test as indicated. Conditional
mutual information was calculated using the condinformation function in the
infotheo package in R. The statistical significance of the mutual information
values was assessed from replicate samples using a two-tailed t test.
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